Tilray Medical

Cannabinoid Treatment Significantly Reduces Fibromyalgia Pain And Improves Quality Of Life, New Tilray-Backed Study Finds
New Study Shows High Use Of Medical Cannabis For Chronic Pain And Arthritis In Older Patients
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
New Study Shows High Use Of Medical Cannabis For Chronic Pain And Arthritis In Older Patients
90% Of Medical Marijuana Patients Over 50 Are Treating Chronic Pain And Arthritis, Finds New Tilray Study
Older Patients Are Choosing Cannabis To Treat Chronic Pain, Arthritis, Anxiety And Insomnia, New Study Shows
Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here's Why

Tilray Medical Recent News

Italians To Enjoy Medical Marijuana Offerings From One Of The Biggest Cannabis Companies In The World
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced that its medical cannabis division, Tilray Medical and FL Group, the company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new medical cannabis c
Tilray Launches 'Take Back Control' Platform To Provide Women With Free Medical Cannabis Resources
Tilray Medical, a medical cannabis division of Tilray Brands, Inc.,(NASDAQ: TLRY) (TSX:TLRY) has launched Take Back Control, a new platform developed to connect women with free reso
Scientists Investigate: Does It Makes Sense To Deny Liver Transplants To Cannabis Users?
Although the CDC estimates that 48.2 million Americans (18 percent of the population) used cannabis in 2019, at least eight states have passed laws prohibiting the denial of a
Tilray's Medical Cannabis Oral Solution Approved For Pharmaceutical Distribution In Italy
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s
Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program
Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa
Tilray Medical Launches Cannabis Education Platform 'WeCare-MedicalCannabis' Across Europe
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, launched a new cannabis education platform, WeCare-MedicalCannabis, dedicated to providing resources and educa
Tilray Medical Expands Portfolio Of Medical Cannabis Products In The UK
Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.
Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada
Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use.